RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)IN BREAST-CANCER PATIENTS (PTS) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

Authors
BEVERIDGE R SCHUSTER M WALLER E STUART R ABBOUD C CRUICKSHANK S MENCHACA D MACRI M CONNAGHAN DG
Citation
R. Beveridge et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)IN BREAST-CANCER PATIENTS (PTS) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Blood, 90(10), 1997, pp. 2580-2580
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
1
Supplement
1
Pages
2580 - 2580
Database
ISI
SICI code
0006-4971(1997)90:10<2580:RDPTOP>2.0.ZU;2-B